Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Intradermal vs Intramuscular Rabies Vaccine in Healthy Bangladeshi Population
NCT07345208Phase 3Not yet recruiting
- Sponsor
- icddr,b
- Start
- Dec 2025
- Primary completion
- May 2027
- Modality
- Whole Inactivated Vaccines
- Countries
- 1
01
Overview
Phase 3, randomised, open-label trial of Rabies vaccine in rabies (2 arms), sponsored by icddr,b. Primary endpoint: Seroconversion Rate at 180 days. Planned start Dec 2025; status: not yet recruiting.
02
Drugs
Rabies vaccine
03
Conditions
rabies
Beyond the preview
Go deeper on NCT07345208.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07345208.